A new review explores how digital twin technology might improve medication management. Digital twins are virtual models of a patient that can simulate how they might respond to different treatments. This review looked at how these models could be used in pharmacy practice to help with precision dosing, managing multiple medications, and choosing the right antibiotics.
The review is a narrative overview, meaning it summarizes ideas and emerging applications rather than presenting new clinical trial results. It did not include patient data or measure actual outcomes. Instead, it focused on the concept of a "clinical-pharmacy translation layer," which is about how to interpret and use digital twin outputs to make medication decisions.
The authors identified several potential benefits, such as more individualized and adaptive treatment plans. However, they also highlighted significant challenges, including ethical, regulatory, and implementation hurdles. For example, it is unclear how to validate these models or ensure they are safe and effective in real-world settings.
Because this is a conceptual review, it does not provide evidence that digital twins work in practice. Patients and healthcare providers should view this as an early-stage idea that requires much more research before it can be used in clinics. The main takeaway is that digital twins hold promise, but they are not ready for routine use.
For now, medication decisions should continue to be based on established medical guidance and individual clinical judgment.
